Clinical potential of proteomics in the diagnosis of ovarian cancer

Expert Review of Molecular Diagnostics - Tập 2 Số 4 - Trang 312-320 - 2002
Ali M. Ardekani1, Lance A. Liotta, Emanuel F. Petricoin
1Proteomics Program, NCI-FDA Clinical Proteomics Program, Center for Biologics Evaluation and Research, Food and Drug Administration and Laboratory of Pathology, Center for Cancer Research, National Cancer Institute and Bethesda, MD 20892, USA.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Venter JC, 2001, Science, 291, 1304, 10.1126/science.1058040

Lander ES, 2001, Nature, 409, 860, 10.1038/35057062

Kawamoto S, 1996, Gene, 174, 151, 10.1016/0378-1119(96)00512-4

Sgroi DC, 1999, In vivo gene expression profile analysis of human breast cancer progression. Cancer Res, 59, 5656

Anderson L, 1997, Electmphotesis, 18, 533

Baselga J, 1998, Cancer Res, 58, 2825

Kantarjian H, 2002, N Engl. J Med, 346, 645, 10.1056/NEJMoa011573

Liotta LA, 2001, Nature, 411, 375, 10.1038/35077241

Emmert-Buck MR, 1996, Science, 274, 998, 10.1126/science.274.5289.998

Bonner RF, 1997, Science, 278, 1481, 10.1126/science.278.5342.1481

10.1016/S0002-9440(10)65251-0

Paweletz CP, 2000, Drug Dev Res, 49, 34, 10.1002/(SICI)1098-2299(200001)49:1<34::AID-DDR6>3.0.CO;2-W

Paweletz CP Charboneau L, Bichsel VE eta]., 2001, Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene, 20, 1981

Liotta LA, 2001, JAMA, 286, 2211, 10.1001/jama.286.18.2211

Emmert-Buck MR, 2000, Mal Carcinog, 27, 158, 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2

Banks RE, 1999, Bectivphotesis, 20, 689

Merchant M, 2000, Electrophoresis, 21, 1164, 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.0.CO;2-0

Wakeley KE, 2000, Cum Opin. Obstet. Gynecol, 12, 43, 10.1097/00001703-200002000-00008

Easton DF, 1995, Am J. Hum. Genet, 56, 265, 10.1002/ajmg.1320560305

Rahman N, 1998, Ann. Rev Genet, 32, 95, 10.1146/annurev.genet.32.1.95

Friedlander ML, 1998, Semin. Oncol, 25, 305

Trope C, 1998, Sernin. Oncol, 25, 372

Kerbrat P, 2001, Br. Cancer, 84, 18, 10.1054/bjoc.2000.1758

Schwartz PE, 1995, Med, 27, 519

McGuire V, 2002, Survival among US women with invasive epithelial ovarian cancer. Gynecol Oncol, 84, 399

Richter R, 1999, j Chmmatogr B. Biomed. Sci App, 726, 25, 10.1016/S0378-4347(99)00012-2

Alizadeh AA, 2000, Nature, 403, 503, 10.1038/35000501

Petricoin EF, 2002, Lancet, 359, 572, 10.1016/S0140-6736(02)07746-2

DePriest PD, 1997, Gynecol Oncol, 65, 408, 10.1006/gyno.1997.4705

Cohen LS, 2001, Gynecol Oncol, 82, 40, 10.1006/gyno.2001.6253

van Nagell JR, 1995, Cancer Metastasis Rev, 76, 2086